Evolus, Inc.
(NASDAQ : EOLS)

( )
EOLS After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc.
1.05%42.410.9%$1199.87m
JNJJohnson & Johnson
1.54%136.380.6%$1051.14m
MRKMerck & Co., Inc.
1.14%79.840.6%$996.51m
BMYBristol-Myers Squibb Company
1.59%51.641.4%$763.48m
LLYEli Lilly and Company
1.41%122.451.0%$755.53m
ABBVAbbVie, Inc.
0.40%80.842.2%$698.69m
NVONovo Nordisk A/S Sponsored ADR Class B
1.15%50.350.1%$71.06m
SNYSanofi Sponsored ADR
2.38%42.550.2%$38.74m
LCILannett Company, Inc.
4.92%9.8137.0%$16.82m
AKTXAkari Therapeutics Plc Sponsored ADR
-1.11%1.851.7%$0.06m
EPIXESSA Pharma Inc
3.88%3.750.1%$0.05m

Company Profile

Evolus, Inc. is a medical aesthetics company. The company is engaged in providing physicians and patients with expanded choices in aesthetic procedures and treatments. Evolus was founded in November, 2012 and is headquartered in Irvine, CA.